At a glance
This program funds early-career kidney cancer researchers who join the Academy of Kidney Cancer Investigators and conduct a kidney cancer project with mentorship and academy participation. It is open to eligible U.S. Department of War organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities, and the principal investigator must be an early-career scholar who is less than seven years from their last postdoctoral research position or clinical fellowship. The announcement says roughly $2.4 million will support about 2 awards, with a total cost cap of $1.2 million per award and a maximum project period of 4 years. Cost sharing is not required. Applications must address at least one FY26 kidney cancer focus area and one kidney cancer disease type, clinical trials are not allowed, and the program does not support painful research on domestic cats or dogs except studies related to military or service animals.
What it funds
Official description from grants.gov
Summary: Initially created in fiscal year 2019 (FY19), the Kidney Cancer Research Program (KCRP) Academy of Kidney Cancer Investigators (AKCI) is a unique interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The Academy pairs Early Career Scholars (ECS) with established investigators (Designated Mentors) under the oversight of the AKCI Leadership Team, a Designated Mentor Panel, and the Kidney Cancer Patient Advocates Panel. The AKCI’s overarching goal is to conduct innovative and impactful kidney cancer research while also developing a vital resource, a network of highly productive kidney cancer researchers conducting cutting edge research that advances the state of the field in kidney cancer and leads to new treatments for individuals living with kidney cancer. Distinctive Features: · Early-Career Scholar: The FY26 KCRP AKCI-ECSA focuses on both the Scholar’s research and their career potential in the kidney cancer field. · Designated Mentor: The Designated Mentor must have a strong record of successful mentorship coupled with a strong record of funding (past and present) and publications in kidney cancer research. · Preliminary Data: Preliminary data to support the feasibility of the research and approaches are required; however, these data do not need to be derived from the kidney cancer research field.
Who can apply
- Unrestricted